NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









KolateAI PharmaTech Inc.

KolateAI PharmaTech Inc.

Private
New JerseyHealthcare & Life Scienceshttps://www.kolate.ai/

Last Round

Convertible Debt

Oct 17, 2024

Est. Valuation

$2.5M

Total Funding Raised

$307,500

Company Overview

KolateAI PharmaTech Inc. is a healthtech company that provides an AI-powered clinical prediction platform for forecasting therapy outcomes and optimizing drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

drug discoveryAI drug discoveryclinical trial monitoringmedical AIhealthcare analyticsvertical SaaSclinical events predictionreal-world evidenceRWEfoundation modelsfrontier AI labAI co-pilotvibe codingelectronic health recordsEHRin-silico researchHEORhealth economics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KolateAI PharmaTech Inc. Comparables

Compare KolateAI PharmaTech Inc. with similar companies based on industry and business-model similarity.

KolateAI PharmaTech Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aitia
77%
Insilico Medicine
76%
Schrödinger
72%

KolateAI PharmaTech Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtOct 17, 2024
AcceleratorJan 8, 2024

Key People

Founding team and executive leadership

Vinodh Balaraman

Co-Founder & CEO

Founding Team

KolateAI PharmaTech Inc. Investors

Notable investors and investment history

KolateAI PharmaTech Inc. investors
InvestorRounds
Entrepreneurs Roundtable AcceleratorConvertible Debt, Accelerator
New Jersey Economic Development AuthorityConvertible Debt
IIT StartupsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Grew 100% QoQ from 3 to 6 employees.

KolateAI PharmaTech Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KolateAI PharmaTech Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KolateAI PharmaTech Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey
Employee Range7
Year Founded2023
Last FundingOct 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.